| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/17/2007 | US7244708 Inhibitors of memapsin 2 and use thereof |
| 07/17/2007 | US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis |
| 07/17/2007 | US7244613 Expression vector comprising nucleotide sequences coding tubercular complex for use in developing vaccines for treatment and prevention of respiratory system disorders; bactericides |
| 07/17/2007 | US7244589 Chimeric immunogens |
| 07/17/2007 | US7244580 Immunogenic composition for use in the diagnosis of allergies in mammals |
| 07/17/2007 | US7244575 Soluble complex comprising a retroviral surface glycoprotein |
| 07/17/2007 | US7244438 Uses for polycationic compounds |
| 07/17/2007 | US7244437 Clostridial toxin derivatives and methods for treating pain |
| 07/17/2007 | US7244436 Clostridial toxin derivatives and methods for treating pain |
| 07/17/2007 | US7244435 DNA vaccine expressing HA1 of equine-2 influenza virus |
| 07/17/2007 | US7244434 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species |
| 07/17/2007 | US7244433 Immunogens; replication-defective; antibodies; host cells; kits |
| 07/17/2007 | US7244431 Composition containing peptide and carrier or diluent wherein the peptide has a length of 8 to 50 amino acids, and three preferably consecutive amino acids of peptide are identical to three amino acids of allergenic protein |
| 07/17/2007 | US7244430 Binding molecules capable of neutralizing West Nile virus and uses thereof |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244428 PRO1357 antibodies |
| 07/17/2007 | US7244427 Isolated bovine IgG heavy chain protein and its use as an antimicrobial |
| 07/17/2007 | US7244425 Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
| 07/17/2007 | US7244422 Enhancing the effect of hepatitis vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | US7244410 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/17/2007 | CA2347278C Vaccine based on attenuated haemophilus somnus |
| 07/17/2007 | CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4 |
| 07/17/2007 | CA2162250C Methods of typing hepatitis c virus and reagents for use therein |
| 07/17/2007 | CA2145535C Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 07/12/2007 | WO2007079457A2 Materials and methods for immunizing against fiv infection |
| 07/12/2007 | WO2007079437A2 Combination antitumor therapies |
| 07/12/2007 | WO2007079390A2 Medicament for topical use |
| 07/12/2007 | WO2007079190A2 Device and method for enhancing immune response by electrical stimulation |
| 07/12/2007 | WO2007079052A2 Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions |
| 07/12/2007 | WO2007078879A2 Lipopeptide compositions and methods of use thereof |
| 07/12/2007 | WO2007078202A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 07/12/2007 | WO2007078196A1 Maturation of dendritic cells. |
| 07/12/2007 | WO2007077934A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 07/12/2007 | WO2007077629A1 Immune adjuvant |
| 07/12/2007 | WO2007077487A2 Method and device for transdermal immunization |
| 07/12/2007 | WO2007077464A2 Chicken virus vaccine and diagnostic |
| 07/12/2007 | WO2007077454A2 A therapeutic composition comprising an inhibitor of an hsp 90 protein |
| 07/12/2007 | WO2007077365A2 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs |
| 07/12/2007 | WO2007077309A1 Combination comprising combretastatin and anticancer agents |
| 07/12/2007 | WO2007076950A1 Anti-cd19 antibodies with reduced immunogenicity |
| 07/12/2007 | WO2007076927A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 07/12/2007 | WO2007076923A1 Combination therapy using anti-egfr and anti-her2 antibodies |
| 07/12/2007 | WO2007054279A8 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 07/12/2007 | WO2007052061A3 Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
| 07/12/2007 | WO2007052057A3 Adminstration routes for priming/boosting with influenza vaccines |
| 07/12/2007 | WO2007047436A3 Methods and materials for producing a generic anti-amyloid immune response in mammals |
| 07/12/2007 | WO2007044616A3 Optimized anti-cd30 antibodies |
| 07/12/2007 | WO2007041432A3 Cross-neutralization of hcv with recombinant proteins |
| 07/12/2007 | WO2007037910A3 Specific removal of activated immune cells |
| 07/12/2007 | WO2007028025A3 Methods and compositions for the treatment and prevention of cholera |
| 07/12/2007 | WO2007022424A3 Laminin receptor targeting method for delivering a toxic agent inside a cell |
| 07/12/2007 | WO2007019541A3 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
| 07/12/2007 | WO2007019301A3 Genes from actinobacillus succinogenes 13oz (atcc 55618) for production of chemicals from the a. succinogenes c4-pathway |
| 07/12/2007 | WO2007011904A3 Recombinant flu vaccines |
| 07/12/2007 | WO2007011606A3 USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS |
| 07/12/2007 | WO2007009081A3 A hexavalent bovine rotavirus reassortant composition designed for use in developing countries |
| 07/12/2007 | WO2007007159A3 Anti-madcam antibodies to treat uterine disorders |
| 07/12/2007 | WO2007006041A8 Imaging and therapeutic method using monocytes |
| 07/12/2007 | WO2007005948A3 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 07/12/2007 | WO2007005605A3 Phosphospecific chemokine receptor antibodies |
| 07/12/2007 | WO2007002261A3 IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF |
| 07/12/2007 | WO2006138627A3 Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein |
| 07/12/2007 | WO2006123256A3 Hivcon: an hiv immunogen and uses thereof |
| 07/12/2007 | WO2006120576A3 Immunogens for meningitidis-a vaccines |
| 07/12/2007 | WO2006105343A3 Dkkl-i splice product modulators for cancer diagnosis and therapy |
| 07/12/2007 | WO2006096800A8 Immunogenic t cell targets in autoimmune hepatitis and methods of use |
| 07/12/2007 | WO2006091798A3 Vaccines and methods for prevention and treatment of drug-resistant hiv-1 and hepatitis b virus |
| 07/12/2007 | WO2006088997A3 Adjuvant activities of b pentamers of lt-iia and lt-iib enterotoxin |
| 07/12/2007 | WO2006044433A3 Methods to treat or prevent viral-associated lymphoproliferative disorders |
| 07/12/2007 | WO2006039638A3 Treating renal cell carcinoma with an anti-tnf human antibody or fragment |
| 07/12/2007 | WO2006031928A3 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof |
| 07/12/2007 | WO2006031795A8 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 07/12/2007 | WO2006025995A3 Compositions and methods using md-2 mutants and chimeric proteins |
| 07/12/2007 | WO2005123126A3 Antibodies against human interleukin-13 and uses therefor |
| 07/12/2007 | WO2005120569A3 Improved therapeutic agent for inos generating illness |
| 07/12/2007 | WO2005097184A3 Antibodies against nogo receptor |
| 07/12/2007 | WO2005047463A3 Hcv replicons containing ns5b from genotype 2b |
| 07/12/2007 | WO2005019409A3 Combinatorial protein library screening by periplasmic expression |
| 07/12/2007 | WO2004104166A3 Administration of hyaluronic acid to enhance the function of transplanted stem cells |
| 07/12/2007 | WO2003102136A3 Antibodies that specifically bind to neurokinin b |
| 07/12/2007 | WO2003077723A3 Methods and devices for detection and therapy of atheromatous plaque |
| 07/12/2007 | US20070162985 measuring an increase in protein expression in blood, urine or cerebrospinal fluid samples, for the diagnosis of diabetes |
| 07/12/2007 | US20070161586 Drug for preventing and treating atherosclerosis |
| 07/12/2007 | US20070161585 Immunopotentiator and method for enhancing immunoactivity using the same |
| 07/12/2007 | US20070161572 Drug therapy for Celiac Sprue |
| 07/12/2007 | US20070161556 Antifungal Therapeutic targets |
| 07/12/2007 | US20070161108 Bob-1 specific T cells and methods to use |
| 07/12/2007 | US20070161088 Beta immunogenic peptide carrier conjugates and methods of producing same |
| 07/12/2007 | US20070161085 Methods of Producing Influenza Vaccine Compositions |
| 07/12/2007 | US20070161080 Antibodies |
| 07/12/2007 | US20070161065 DIAGNOSIS, PREVENTION AND TREATMENT OF CROHN'S DISEASE USING THE OmpC ANTIGEN |
| 07/12/2007 | US20070161046 Truncated aggrecanase molecules |
| 07/12/2007 | US20070161040 Hybrid proteins of active-site serine beta-lactamase |
| 07/12/2007 | US20070161034 Compositions and methods for the therapy and diagnosis of colon cancer |
| 07/12/2007 | US20070160634 Methods for reducing somatic cell count in milk |
| 07/12/2007 | US20070160633 Methods for enhancing therapeutic effects of a neurotoxin |
| 07/12/2007 | US20070160632 Polyinosinic acid-polycytidylic acid-based adjuvant |
| 07/12/2007 | US20070160631 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 07/12/2007 | US20070160630 Hepatitis-c virus 4, 5 and 6 |